LXEO
Lexeo Therapeutics, Inc.
+0.10 (+2.40%)4.26USD675K成交股數350M市值–本益比(近四季)534.4股價營收比–營收年增(近四季)2026-11-04下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 7 · 300K · 4 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 636K |
| 近 180 天 淨額 | −636K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 | 08-19 | Otero Jose Manuel | Chief Operating Officer | S 公開市場賣出 | 1.3K | 4.96 | 6K | 136K | SEC |
| 2026-08-18 | 08-19 | Tamayo Louis Edward | Chief Financial Officer | S 公開市場賣出 | 4.1K | 4.91 | 20K | 92.9K | SEC |
| 2026-08-18 | 08-19 | Townsend Richard Nolan | Chief Executive Officer | S 公開市場賣出 | 3.3K | 4.95 | 17K | 374K | SEC |
| 2026-07-01 | 07-01 | Otero Jose Manuel | Chief Operating Officer | S 公開市場賣出 | 4.7K | 4.48 | 21K | 137K | SEC |
| 2026-07-01 | 07-01 | Bhalla Narinder Pal | Chief Medical Officer | S 公開市場賣出 | 22.3K | 4.42 | 99K | 82.2K | SEC |
| 2026-07-01 | 07-01 | Tamayo Louis Edward | Chief Financial Officer | S 公開市場賣出 | 4.6K | 4.49 | 21K | 97.0K | SEC |
| 2026-07-01 | 07-01 | Townsend Richard Nolan | Chief Executive Officer | S 公開市場賣出 | 25.9K | 4.48 | 116K | 378K | SEC |
| 2026-06-29 | 07-01 | Tamayo Louis Edward | Chief Financial Officer | A 獲配股票 | 12.0K | – | – | 102K | SEC |
| 2026-06-29 | 07-01 | Townsend Richard Nolan | Chief Executive Officer | A 獲配股票 | 67.0K | – | – | 404K | SEC |
| 2026-06-29 | 07-01 | Otero Jose Manuel | Chief Operating Officer | A 獲配股票 | 12.1K | – | – | 142K | SEC |
| 2026-06-29 | 07-01 | Bhalla Narinder Pal | Chief Medical Officer | A 獲配股票 | 55.0K | – | – | 105K | SEC |
| 2026-05-18 | 05-20 | Townsend Richard Nolan | Chief Executive Officer | S 公開市場賣出 | 3.3K | 5.06 | 17K | 337K | SEC |
| 2026-05-18 | 05-20 | Otero Jose Manuel | Chief Operating Officer | S 公開市場賣出 | 1.3K | 5.07 | 7K | 130K | SEC |
| 2026-04-06 | 04-07 | Townsend Richard Nolan | Chief Executive Officer | S 公開市場賣出(10b5-1) | 55.0K | 5.69 | 313K | 340K | SEC |
| 2026-03-13 | 03-17 | Otero Jose Manuel | Chief Operating Officer | A 獲配股票 | 5.9K | 2.64 | 16K | 131K | SEC |
| 2026-03-13 | 03-17 | Townsend Richard Nolan | Chief Executive Officer | A 獲配股票 | 2.6K | 2.64 | 7K | 395K | SEC |
| 2026-02-18 | 02-20 | Townsend Richard Nolan | Chief Executive Officer | S 公開市場賣出 | 10.2K | 6.38 | 65K | 392K | SEC |
| 2026-02-18 | 02-20 | Otero Jose Manuel | Chief Operating Officer | S 公開市場賣出 | 3.0K | 6.40 | 19K | 125K | SEC |
| 2026-02-13 | 02-17 | Bhalla Narinder Pal | Chief Medical Officer | A 獲配股票 | 49.5K | – | – | 49.5K | SEC |
| 2026-02-04 | 02-06 | Townsend Richard Nolan | Chief Executive Officer | A 獲配股票 | 162K | – | – | 403K | SEC |
| 2026-02-04 | 02-06 | Otero Jose Manuel | Chief Operating Officer | A 獲配股票 | 65.0K | – | – | 128K | SEC |
| 2026-02-04 | 02-06 | Tamayo Louis Edward | Chief Financial Officer | A 獲配股票 | 44.7K | – | – | 89.7K | SEC |
| 2025-11-18 | 02-20 | Otero Jose Manuel | Chief Operating Officer | S 公開市場賣出 | 721 | 9.27 | 7K | 63.5K | SEC |
| 2025-11-18 | 11-20 | See Tai Sandi | Chief Development Officer | S 公開市場賣出 | 386 | 9.27 | 4K | 65.5K | SEC |
| 2025-11-18 | 11-20 | Adler Eric | Chief Medical Officer | S 公開市場賣出 | 615 | 9.27 | 6K | 72.6K | SEC |
| 2025-11-18 | 11-20 | Robertson Jenny | Chief Legal Officer | S 公開市場賣出 | 549 | 9.27 | 5K | 68.4K | SEC |
| 2025-11-18 | 11-20 | Townsend Richard Nolan | Chief Executive Officer | S 公開市場賣出 | 1.1K | 9.27 | 10K | 241K | SEC |
| 2025-10-17 | 10-17 | Robertson Jenny | Chief Legal Officer | S 公開市場賣出 | 3.5K | 8.94 | 31K | 69.0K | SEC |
| 2025-10-17 | 10-17 | Adler Eric | Chief Medical Officer | S 公開市場賣出 | 3.3K | 8.94 | 30K | 73.3K | SEC |
| 2025-10-17 | 10-17 | Adler Eric | Chief Medical Officer | S 公開市場賣出 | 38 | 9.56 | 363.28 | 73.3K | SEC |
| 2025-10-17 | 10-17 | Robertson Jenny | Chief Legal Officer | S 公開市場賣出 | 40 | 9.56 | 382.40 | 68.9K | SEC |
| 2025-10-17 | 10-17 | Townsend Richard Nolan | Chief Executive Officer | S 公開市場賣出 | 13.0K | 8.94 | 116K | 242K | SEC |
| 2025-10-17 | 10-17 | Townsend Richard Nolan | Chief Executive Officer | S 公開市場賣出 | 148 | 9.56 | 1K | 242K | SEC |
| 2025-10-17 | 10-17 | See Tai Sandi | Chief Development Officer | S 公開市場賣出 | 3.8K | 8.94 | 34K | 65.9K | SEC |
| 2025-10-17 | 10-17 | See Tai Sandi | Chief Development Officer | S 公開市場賣出 | 44 | 9.56 | 420.64 | 65.9K | SEC |
| 2025-10-17 | 10-17 | Otero Jose Manuel | Chief Technical Officer | S 公開市場賣出 | 2.1K | 8.94 | 19K | 64.2K | SEC |
| 2025-10-17 | 10-17 | Otero Jose Manuel | Chief Technical Officer | S 公開市場賣出 | 24 | 9.56 | 229.44 | 64.2K | SEC |
| 2025-10-15 | 10-17 | Townsend Richard Nolan | Chief Executive Officer | A 獲配股票 | 33.0K | – | – | 255K | SEC |
| 2025-10-15 | 10-17 | Otero Jose Manuel | Chief Technical Officer | A 獲配股票 | 5.9K | – | – | 66.3K | SEC |
| 2025-10-15 | 10-17 | Robertson Jenny | Chief Legal Officer | A 獲配股票 | 9.9K | – | – | 72.5K | SEC |
| 2025-10-15 | 10-17 | See Tai Sandi | Chief Development Officer | A 獲配股票 | 10.9K | – | – | 69.8K | SEC |
| 2025-10-15 | 10-17 | Adler Eric | Chief Medical Officer | A 獲配股票 | 9.6K | – | – | 76.6K | SEC |
| 2025-09-12 | 09-16 | Townsend Richard Nolan | Chief Executive Officer | A 獲配股票 | 2.2K | 2.64 | 6K | 222K | SEC |
| 2025-08-29 | 09-03 | Tamayo Louis Edward | Chief Financial Officer | A 獲配股票 | 45.0K | – | – | 45.0K | SEC |
| 2025-08-18 | 11-20 | Otero Jose Manuel | Chief Technical Officer | S 公開市場賣出 | 721 | 9.27 | 7K | 63.5K | SEC |
| 2025-08-18 | 09-10 | Townsend Richard Nolan | Chief Executive Officer | S 公開市場賣出 | 1.1K | 4.67 | 5K | 220K | SEC |
| 2025-08-18 | 08-20 | Otero Jose Manuel | Chief Technical Officer | S 公開市場賣出 | 2.8K | 4.67 | 13K | 60.4K | SEC |
| 2025-08-18 | 08-20 | See Tai Sandi | Chief Development Officer | S 公開市場賣出 | 382 | 4.67 | 2K | 58.9K | SEC |
| 2025-08-18 | 08-20 | Townsend Richard Nolan | Chief Executive Officer | S 公開市場賣出 | 2.7K | 4.67 | 13K | 220K | SEC |
| 2025-08-18 | 08-20 | Adler Eric | Chief Medical Officer | S 公開市場賣出 | 608 | 4.67 | 3K | 67.1K | SEC |
| 2025-08-18 | 08-20 | Robertson Jenny | Chief Legal Officer | S 公開市場賣出 | 542 | 4.67 | 3K | 62.6K | SEC |
| 2025-05-16 | 05-20 | See Tai Sandi | Chief Development Officer | S 公開市場賣出 | 367 | 2.77 | 1K | 59.2K | SEC |
| 2025-05-16 | 05-20 | Robertson Jenny | Chief Legal Officer | S 公開市場賣出 | 521 | 2.77 | 1K | 63.1K | SEC |
| 2025-05-16 | 05-20 | Adler Eric | Chief Medical Officer | S 公開市場賣出 | 585 | 2.77 | 2K | 67.7K | SEC |
| 2025-05-16 | 05-20 | Townsend Richard Nolan | Chief Executive Officer | S 公開市場賣出 | 1.1K | 2.77 | 3K | 221K | SEC |
| 2025-03-14 | 04-09 | Robertson Jenny | Chief Legal Officer | A 獲配股票 | 5.7K | 2.61 | 15K | 63.6K | SEC |
| 2025-03-14 | 04-09 | See Tai Sandi | Chief Development Officer | A 獲配股票 | 5.7K | 2.61 | 15K | 59.6K | SEC |
| 2025-03-14 | 04-09 | Otero Jose Manuel | Chief Technical Officer | A 獲配股票 | 5.7K | 2.61 | 15K | 63.2K | SEC |
| 2025-03-14 | 04-01 | Townsend Richard Nolan | Chief Executive Officer | A 獲配股票 | 2.1K | 2.61 | 6K | 222K | SEC |
| 2025-02-19 | 02-21 | Townsend Richard Nolan | Chief Executive Officer | S 公開市場賣出 | 4.3K | 4.41 | 19K | 220K | SEC |
| 2025-02-19 | 02-21 | See Tai Sandi | Chief Development Officer | S 公開市場賣出 | 1.5K | 4.41 | 7K | 53.9K | SEC |
| 2025-02-19 | 02-21 | Robertson Jenny | Chief Legal Officer | S 公開市場賣出 | 2.1K | 4.41 | 9K | 57.9K | SEC |
| 2025-02-19 | 02-21 | Adler Eric | Chief Medical Officer | S 公開市場賣出 | 2.4K | 4.41 | 10K | 68.3K | SEC |
| 2025-01-17 | 01-22 | Rasbach Kyle | Chief Financial Officer | A 獲配股票 | 40.9K | – | – | 40.9K | SEC |
| 2025-01-07 | 01-10 | Adler Eric | Chief Medical Officer | A 獲配股票 | 43.8K | – | – | 70.6K | SEC |
| 2025-01-07 | 01-10 | See Tai Sandi | Chief Development Officer | A 獲配股票 | 38.8K | – | – | 55.4K | SEC |
| 2025-01-07 | 01-10 | Robertson Jenny | Chief Legal & Admin Officer | A 獲配股票 | 36.3K | – | – | 60.0K | SEC |
| 2025-01-07 | 01-10 | Otero Jose Manuel | Chief Technical Officer | A 獲配股票 | 26.3K | – | – | 57.5K | SEC |
| 2025-01-07 | 01-10 | Townsend Richard Nolan | Chief Executive Officer | A 獲配股票 | 104K | – | – | 224K | SEC |
| 2024-12-10 | 12-12 | Townsend Richard Nolan | Chief Executive Officer | S 公開市場賣出(10b5-1) | 2.5K | 8.20 | 21K | 121K | SEC |
| 2024-12-10 | 12-12 | Townsend Richard Nolan | Chief Executive Officer | M 選擇權執行 | 2.5K | 2.33 | 6K | 123K | SEC |
| 2024-11-25 | 11-26 | CHOLMONDELEY PAULA H | Director | P 公開市場買進 | 15.0K | 6.99 | 105K | 30.6K | SEC |
| 2024-11-11 | 11-13 | Townsend Richard Nolan | Chief Executive Officer | S 公開市場賣出(10b5-1) | 2.5K | 7.82 | 20K | 121K | SEC |
| 2024-11-11 | 11-13 | Townsend Richard Nolan | Chief Executive Officer | M 選擇權執行 | 2.5K | 2.33 | 6K | 123K | SEC |
| 2024-10-10 | 10-15 | Townsend Richard Nolan | Chief Executive Officer | S 公開市場賣出(10b5-1) | 5.0K | 8.10 | 41K | 121K | SEC |
| 2024-10-10 | 10-15 | Townsend Richard Nolan | Chief Executive Officer | M 選擇權執行 | 5.0K | 2.33 | 12K | 126K | SEC |
| 2024-09-10 | 09-11 | Townsend Richard Nolan | Chief Executive Officer | M 選擇權執行 | 5.0K | 2.33 | 12K | 126K | SEC |
| 2024-09-10 | 09-11 | Townsend Richard Nolan | Chief Executive Officer | S 公開市場賣出(10b5-1) | 5.0K | 10.65 | 53K | 121K | SEC |
| 2024-08-12 | 08-13 | Townsend Richard Nolan | Chief Executive Officer | S 公開市場賣出(10b5-1) | 5.0K | 11.53 | 58K | 121K | SEC |
| 2024-08-12 | 08-13 | Townsend Richard Nolan | Chief Executive Officer | M 選擇權執行 | 5.0K | 2.33 | 12K | 126K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 6.4M | 29.7M | 新進 | 新進 |
| Affinity Asset Advisors, LLC | 5.8M | 27.0M | 新進 | 新進 |
| BlackRock, Inc. | 5.7M | 26.7M | 新進 | 新進 |
| RA CAPITAL MANAGEMENT, L.P. | 5.0M | 23.3M | 新進 | 新進 |
| Frazier Life Sciences Management, L.P. | 4.8M | 22.5M | 新進 | 新進 |
| STATE STREET CORP | 4.4M | 20.3M | 新進 | 新進 |
| Vestal Point Capital, LP | 4.3M | 20.1M | 新進 | 新進 |
| Paradigm Biocapital Advisors LP | 4.2M | 19.4M | 新進 | 新進 |
| Jupiter Topco LLC | 4.0M | 18.4M | 新進 | 新進 |
| ORBIMED ADVISORS LLC | 3.9M | 18.4M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 3.9M | 18.1M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.1M | 14.6M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 2.8M | 13.2M | 新進 | 新進 |
| Nantahala Capital Management, LLC | 2.6M | 12.1M | 新進 | 新進 |
| Woodline Partners LP | 2.5M | 11.6M | 新進 | 新進 |
| Balyasny Asset Management L.P. | 2.4M | 11.2M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 2.1M | 10.0M | 新進 | 新進 |
| 683 Capital Management, LLC | 1.9M | 8.7M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7M | 8.1M | 新進 | 新進 |
| ADAR1 Capital Management, LLC | 1.6M | 7.3M | 新進 | 新進 |
| Avoro Capital Advisors LLC | 1.5M | 6.9M | 新進 | 新進 |
| Qube Research & Technologies Ltd | 1.4M | 6.4M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 1.3M | 6.0M | 新進 | 新進 |
| Spruce Street Capital LP | 929K | 4.3M | 新進 | 新進 |
| Blackstone Inc. | 905K | 4.2M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 142 +3 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 142 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 89.5M · 100.0% |
| 合計季末市值 | 417M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 20.5M |
|---|---|
| 與上期比 | +0.0% |
| 佔流通股數 | 24.97% |
| 日均成交量 | 764K |
| 回補天數 | 26.8 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 20.5M | +0.0% | 24.97% | 764K | 26.8 |
| 2026-08-14 | 20.5M | +20.1% | 24.96% | 1.0M | 19.8 |
| 2026-07-31 | 17.1M | +4.3% | 20.79% | 1.0M | 16.9 |
| 2026-07-15 | 16.3M | +1.4% | 19.93% | 836K | 19.6 |
| 2026-06-30 | 16.1M | +14.5% | 19.66% | 1.2M | 14.0 |
| 2026-06-15 | 14.1M | +2.3% | 17.17% | 749K | 18.8 |
| 2026-05-29 | 13.8M | +4.3% | 16.79% | 794K | 17.4 |
| 2026-05-15 | 13.2M | +1.1% | 16.10% | 702K | 18.8 |
| 2026-04-30 | 13.1M | +3.7% | 15.92% | 691K | 18.9 |
| 2026-04-15 | 12.6M | +0.9% | 15.36% | 1.3M | 9.9 |
| 2026-03-31 | 12.5M | +5.9% | 15.23% | 884K | 14.1 |
| 2026-03-13 | 11.8M | +6.0% | 14.38% | 1.0M | 11.4 |
| 2026-02-27 | 11.1M | -2.9% | 13.56% | 584K | 19.1 |
| 2026-02-13 | 11.5M | -4.3% | 13.97% | 893K | 12.8 |
| 2026-01-30 | 12.0M | +4.5% | 14.60% | 823K | 14.6 |
| 2026-01-15 | 11.5M | +5.8% | 13.96% | 1.7M | 6.9 |
| 2025-12-31 | 10.8M | +52.5% | 13.20% | 1.9M | 5.9 |
| 2025-12-15 | 7.1M | +17.6% | 8.66% | 985K | 7.2 |
| 2025-11-28 | 6.0M | +7.1% | 7.36% | 1.0M | 5.8 |
| 2025-11-14 | 5.6M | +8.8% | 6.87% | 1.6M | 3.4 |
| 2025-10-31 | 5.2M | -29.1% | 6.32% | 1.3M | 4.0 |
| 2025-10-15 | 7.3M | +22.7% | 8.92% | 1.6M | 4.7 |
| 2025-09-30 | 6.0M | +1.2% | 7.27% | 956K | 6.2 |
| 2025-09-15 | 5.9M | +12.6% | 7.18% | 538K | 11.0 |
| 2025-08-29 | 5.2M | -1.0% | 6.38% | 309K | 16.9 |
| 2025-08-15 | 5.3M | +0.7% | 6.44% | 291K | 18.2 |